Development of an integrated generic platform for the engineering, production and purification of monclonal antibodies
Lead Participant:
OXYRANE UK LIMITED
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| OXYRANE UK LIMITED | £3,149,256 | £ 1,353,800 |
Participant |
||
| ALLERGAN BIOLOGICS LIMITED | £167,986 | £ 74,912 |
| UNIVERSITY OF CAMBRIDGE | £492,772 | £ 492,772 |
People |
ORCID iD |